Nanjing Zhishangheng E-commerce Co., Ltd. – Trademark Portfolio

Entity Type: 99

Nanjing Zhishangheng E-commerce Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include KLZD. The owner is based in Nanjing City, Jiangsu Prov..

Rm. 211, Bldg. 01, No.1 Lixin Rd., Jiangbei New Dist.,

Nanjing City, Jiangsu Prov. 210000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KLZD
KLZD
Registered 2025

Trademark Classifications

Nanjing Zhishangheng E-commerce Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Nanjing Zhishangheng E-commerce Co., Ltd. have?

Nanjing Zhishangheng E-commerce Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Nanjing Zhishangheng E-commerce Co., Ltd. file in?

Nanjing Zhishangheng E-commerce Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Nanjing Zhishangheng E-commerce Co., Ltd.'s most well-known trademarks?

Nanjing Zhishangheng E-commerce Co., Ltd.'s registered trademark portfolio includes well-known marks such as KLZD. These are among 1 currently registered trademark in the portfolio.

What is Nanjing Zhishangheng E-commerce Co., Ltd.'s trademark registration success rate?

Nanjing Zhishangheng E-commerce Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.